Amgen Inc. (AMG)
XHAN
Closed
Aug 25, 2026
Day's Range
379.1052 wk Range
230.05Overview - AMG - Amgen Inc.
Key Statistics
Valuation
Enterprise Value
45.47B
P/E (Trailing)
‪26.71‬
PEG Ratio
‪0.40‬
Price / Book
‪17.68‬
EV / EBITDA
‪2.69‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪67.24%‬
Operating Margin
‪31.92%‬
Return on Assets
‪8.51%‬
Return on Equity
‪89.06%‬
Ownership
Shares Outstanding
541.00M
Price stats
50-Day Avg
‪329.32‬
200-Day Avg
‪303.86‬
Dividends
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - AMG - Amgen Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XHAN.
- AMGXHANAmgen Inc.+20.49%52-week change22.14P/E (Trailing)‪67.24%‬Profit Margin
- NOVXHANNov Inc.+40.08%52-week change79.84P/E (Trailing)‪1.04%‬Profit Margin
- BAYNXHANBayer AG+41.84%52-week change-13.17P/E (Trailing)‪58.75%‬Profit Margin
- 6MKXHANMerck & Co., Inc.+40.00%52-week change15.37P/E (Trailing)‪74.80%‬Profit Margin
- IDPXHANBiogen Inc.+33.96%52-week change19.46P/E (Trailing)‪75.69%‬Profit Margin
- JNJXHANJohnson & Johnson+30.51%52-week change17.34P/E (Trailing)‪67.87%‬Profit Margin
- RHOXHANRoche Holding AG+25.68%52-week change23.78P/E (Trailing)‪73.72%‬Profit Margin
Profile Summary - AMG - Amgen Inc.
About
Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on innovative medicines addressing serious illnesses in areas such as oncology, inflammation, cardiovascular disease, bone health, nephrology, and neurology. Key products target…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
